Clips from the 10Q:
-Sales were $605,000 during the third quarter of 1997, an increase of $473,000 from the $132,000 reported during the same period in 1996. The increase was related solely to the sales of Millennium(TM) systems to the Company's German distributor. The sales of endodontic products during the third quarter of 1997 were comparable to those reported for the same quarter in 1996.
-Sales for the nine-month period ended September 30, 1997 increased to $1,172,000, up $735,000 from the $437,000 reported for the comparable period in 1996. The increase was due to shipments of the Millennium(TM) system combined with an increase in sales of endodontic products amounting to approximately $105,000 for the nine-month period ended September 30, 1997 compared to the same period in 1996.
-...the Company intends to introduce to the domestic market a laser-based system in a configuration that is designed for lower power settings than those of the Millennium(TM) system, under the name DermaLase(TM). The Company is presently developing its marketing plan for the DermaLase(TM) system and anticipates commencement of production of DermaLase(TM) in the first quarter of 1998. (FLS)
-The Company expects to realize improved margins on its Millennium(TM) sales during the balance of 1997 through improved production layouts and efficiencies and improved pricing in its cost of materials.
-Management believes that significant additional resources will be required by the first quarter of 1998 to complete the process designed to lead to FDA clearance to market the Company's laser-based technologies for hard tissue applications in the United States and to fund the Company's working capital needs. The Company expects to generate the necessary capital resources through the revenue generated by its new products, the issuance of equity securities in either public offerings or private placements, or debt financing. |
